Skip to content

A CLINICAL TRIAL ON AYURVEDIC THEREPY IN VAGINAL WHITE DISCHARGE.

A STUDY ON EFFICACY OF UDUMBARADI TAILA YONI PICHU AND UDUMBARADI KASHAYA YONI PRAKSHALANA IN MANAGEMENT OF SWETA PRADARA W. S. R. TO BACTERIAL VAGINOSIS - not applicable

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/032891
Enrollment
30
Registered
2021-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N898- Other specified noninflammatory disorders of vagina

Interventions

Intervention1: administration of Yoni Pichu of Udumbaradi Taila : Group A (Trial drug): Udumbaradi Taila1 â?? Yoni Pichu (dimensions 1 cm X 2 cm soaked in 10 ml. of Udumbaradi Taila) Drug: Udumbarad

Sponsors

National Institute of Ayurveda Jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Married women aged between 18 years to 40 years with regular menstrual cycle. 2. Presence of 3 out of 4 Amselâ??s diagnostic criteria for Bacterial Vaginosis: Off white (milky or grey), thin, homogeneous, adherent vaginal discharge, with minimal or absent pruritis. Vaginal pH > 4.5 Positive â??whiff testâ?? (fishy odor of the vaginal discharge with the addition of a drop of 10% KOH). Presence of clue cells >=20% of the total epithelial cells on microscopic examination of the saline wet mount. 3. Patient agrees to refrain from use of douches, oral or intra vaginal antibiotics or antifungal agents or lubricants during the entire study period. 4. Patient agrees to use condom/ abstinence during the treatment period. 5. Patient willing and agrees to participate for three months and signs informed consent.

Exclusion criteria

Exclusion criteria: 1. Unmarried women of age 40 yrs. 2. Patient with Pelvic inflammatory disease, Cervicitis or other vaginal infections like Trichomoniasis or candida etc. or non infectious vulvo-vaginitis/ cervicitis. 3. Patients with evidence of malignancy or cervical intra epithelial neoplasia or cervical carcinoma. 4. Patient with history of untreated sexually transmitted disease or known to be HIV positive. 5. Patient with positive pregnancy test/ Lactating woman. 6. Patient has received antifungal or antimicrobial therapy (systemic or intra-vaginal) within last 14 days prior to enrollment.

Design outcomes

Primary

MeasureTime frame
Cure from symptoms and signs of Sweta Pradara with special reference to Bacterial Vaginosis. Timepoint: 85-90 days

Secondary

MeasureTime frame
Cure of associated symptoms like burning, pain, itching and low backacheTimepoint: 90 days

Countries

India

Contacts

Public ContactDr shashi bala

National Institute of Ayurveda Jaipur

pushpalathania@gmail.com9413206790

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026